Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1958 Sep 1;108(3):329–341. doi: 10.1084/jem.108.3.329

OCCURRENCE OF R ANTIGEN SPECIFIC FOR GROUP A TYPE 3 STREPTOCOCCI

Rebecca C Lancefield 1; With the Technical Assistance of William N. Everly1
PMCID: PMC2136879  PMID: 13575670

Abstract

Approximately 50 per cent of Group A, Type 3 streptococci contain a hitherto undescribed antigen found only in Group A, Type 3 organisms. It is serologically distinct from Type 3 M antigen and is designated as 3 R antigen. Strains containing 3 R antigen but no Type 3 M antigen are "glossy," avirulent Type 3 variants. These strains can be obtained by repeated transfers of virulent M-containing streptococci in artificial media under unfavorable conditions of growth. These degraded streptococci recover Type 3 M antigen during serial passage through mice. The amount of 3 R antigen in a strain is not affected by a decrease or increase in M antigen. The 3 R antigen is unrelated to virulence. Antibodies to this antigen do not protect mice against infection or promote phagocytosis in bactericidal tests. The 3 R antigen-antibody system can give rise to confusion in M-precipitin reactions. In all these properties 3 R antigen is similar to 28 R antigen, although in certain other properties the two R antigens are not identical. They are serologically distinct. Virulence and ability to grow in normal human blood under the conditions of the bactericidal test are correlated with the presence of M antigen of Group A, Type 3 streptococci. Mouse protection and specific inhibition of growth of Type 3 streptococci by phagocytosis in bactericidal tests are associated with the presence of Type 3 anti-M antibodies.

Full Text

The Full Text of this article is available as a PDF (703.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dochez A. R., Avery O. T., Lancefield R. C. STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : I. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS. J Exp Med. 1919 Sep 1;30(3):179–213. doi: 10.1084/jem.30.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. HAMBLY J. S. The precipitating antigen of Streptococcus pyogenes type 4. J Gen Microbiol. 1958 Feb;18(1):285–293. doi: 10.1099/00221287-18-1-285. [DOI] [PubMed] [Google Scholar]
  3. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. LANCEFIELD R. C., PERLMANN G. E. Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus. J Exp Med. 1952 Jul;96(1):71–82. doi: 10.1084/jem.96.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lancefield R. C. THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS. J Exp Med. 1928 Jan 1;47(1):91–103. doi: 10.1084/jem.47.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MAXTED W. R. Occurrence of the M. substance of type 28 group A in streptococci of Lancefield groups B, C and G. J Gen Microbiol. 1949 Jan;3(1):1–6. doi: 10.1099/00221287-3-1-1. [DOI] [PubMed] [Google Scholar]
  7. MAXTED W. R. The M and T antigens of Streptococcus pyogenes type 2. J Pathol Bacteriol. 1953 Apr;65(2):345–354. doi: 10.1002/path.1700650207. [DOI] [PubMed] [Google Scholar]
  8. ROTHBARD S., WATSON R. F. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med. 1948 Jun 1;87(6):521–533. doi: 10.1084/jem.87.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. WORMALD P. J. Some observations on the influence of the micro-environment on loss of M substance in strains of Streptococcus pyogenes. J Hyg (Lond) 1956 Mar;54(1):89–98. doi: 10.1017/s0022172400044338. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES